Skip to main content
Clinical Trials/NCT03488745
NCT03488745
Unknown
Not Applicable

Examining an App-based Mental Health Intervention for Cancer Patients and Caregivers

University of Virginia1 site in 1 country50 target enrollmentMarch 27, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mental Health Wellness 1
Sponsor
University of Virginia
Enrollment
50
Locations
1
Primary Endpoint
Clinical Mood Symptoms
Last Updated
8 years ago

Overview

Brief Summary

A cancer diagnosis affects not only patients but also their caregivers. The purpose of this study is to test the feasibility of using a mobile app suite, IntelliCare, to improve the mental health of cancer patients and caregivers.

Detailed Description

Cancer patients and/or their caregivers will receive access to the mobile app suite, IntelliCare, as well as phone coaching that will focus on how to use the apps. IntlliCare is composed of separate apps that each target a specific aspect of mental health (e.g., reducing worry). The apps are interactive and designed for users to engage in short time bursts (e.g., less than a minute). IntelliCare was originally designed to be paired with phone coaching that focuses on how to use the apps and overcome barriers to usage.

Registry
clinicaltrials.gov
Start Date
March 27, 2018
End Date
October 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Philip Chow, Ph.D.

Assistant Professor

University of Virginia

Eligibility Criteria

Inclusion Criteria

  • Willingness and ability to comply with scheduled visits and study procedures.
  • Caregiver/support person of patient undergoing treatment for cancer in the Breast Care Clinic OR patient undergoing treatment for cancer in the Breast Care Clinic
  • Owns a smart phone or they are willing to carry one during the study if one is provided.

Exclusion Criteria

  • Under 18 years old
  • Non-English Speaker

Outcomes

Primary Outcomes

Clinical Mood Symptoms

Time Frame: Change in clinical mood symptoms from baseline to post-intervention (7 weeks after baseline)

Patient Health Questionnaire-4 contains measures clinical symptoms of mood and anxiety disorders. Scores on this scale range from 0-12, with a higher score indicating greater severity of mood symptoms. Unlike the Patient-Reported Outcomes Measurement Information System scales, this scale has pre-determined clinical cutoffs for mild, moderate, and severe symptoms, which will be used to classify severity of mood symptoms.

Depression Symptoms

Time Frame: Change in depression symptoms from baseline to post-intervention (7 weeks after baseline)

Patient-Reported Outcomes Measurement Information System 4-Item Depression Scale (from 29-item Profile), measures depression on a continuous scale. Scores on this scale range from 4-20, with a higher score indicating greater severity of depression.

Anxiety Symptoms

Time Frame: Change in anxiety symptoms from baseline to post-intervention (7 weeks after baseline)

Patient-Reported Outcomes Measurement Information System 4-Item Anxiety Scale (from 29-item Profile), measures anxiety on a continuous scale. Scores on this scale range from 4-20, with a higher score indicating greater severity of anxiety.

Secondary Outcomes

  • Physical Function(Change in physical function from baseline to post-intervention (7 weeks after baseline))
  • Sleep Quality(Change in sleep disturbance from baseline to post-intervention (7 weeks after baseline))
  • Fatigue(Change in fatigue from baseline to post-intervention (7 weeks after baseline))
  • Pain Interference(Change in Pain Interference from baseline to post-intervention (7 weeks after baseline))
  • Caregiver Self-Efficacy(Change in Caregiver Self-Efficacy from baseline to post-intervention (7 weeks after baseline))
  • Life Meaning/purpose(Change in life meaning/purpose from baseline to post-intervention (7 weeks after baseline))
  • Patient Health Care Utilization(Change in Patient Health Care Utilization from baseline to post-intervention (7 weeks after baseline))
  • Ability to Participate in Social Roles and Activities(Change in Ability to Participate in Social Roles and Activities from baseline to post-intervention (7 weeks after baseline))
  • Caregiver Health Care Utilization(Change in Caregiver Health Care Utilization from baseline to post-intervention (7 weeks after baseline))

Study Sites (1)

Loading locations...

Similar Trials